vs

Side-by-side financial comparison of ARK RESTAURANTS CORP (ARKR) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $40.7M, roughly 1.9× ARK RESTAURANTS CORP). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -9.4%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-1.8M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -1.8%).

ARK Restaurants Corp operates a diversified portfolio of dining establishments across the United States, spanning casual dining, fast-casual, and upscale fine dining segments. Its offerings include American comfort food, BBQ, seafood, and Italian cuisine, serving local community patrons and tourist visitors across dozens of locations in multiple states.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

ARKR vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.9× larger
PBYI
$75.5M
$40.7M
ARKR
Growing faster (revenue YoY)
PBYI
PBYI
+37.1% gap
PBYI
27.7%
-9.4%
ARKR
More free cash flow
PBYI
PBYI
$16.2M more FCF
PBYI
$14.4M
$-1.8M
ARKR
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-1.8%
ARKR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ARKR
ARKR
PBYI
PBYI
Revenue
$40.7M
$75.5M
Net Profit
$896.0K
Gross Margin
69.3%
Operating Margin
2.7%
22.7%
Net Margin
2.2%
Revenue YoY
-9.4%
27.7%
Net Profit YoY
-71.7%
EPS (diluted)
$0.25
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARKR
ARKR
PBYI
PBYI
Q4 25
$40.7M
$75.5M
Q3 25
$37.3M
$54.5M
Q2 25
$43.7M
$52.4M
Q1 25
$39.7M
$46.0M
Q4 24
$45.0M
$59.1M
Q3 24
$43.4M
$80.5M
Q2 24
$50.4M
$47.1M
Q1 24
$42.3M
$43.8M
Net Profit
ARKR
ARKR
PBYI
PBYI
Q4 25
$896.0K
Q3 25
$-1.9M
$8.8M
Q2 25
$-3.5M
$5.9M
Q1 25
$-9.3M
$3.0M
Q4 24
$3.2M
Q3 24
$-4.5M
$20.3M
Q2 24
$640.0K
$-4.5M
Q1 24
$-1.4M
$-4.8M
Gross Margin
ARKR
ARKR
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
ARKR
ARKR
PBYI
PBYI
Q4 25
2.7%
22.7%
Q3 25
-4.6%
17.6%
Q2 25
-7.8%
12.7%
Q1 25
-11.6%
8.7%
Q4 24
12.6%
22.6%
Q3 24
-12.7%
27.4%
Q2 24
1.6%
-4.6%
Q1 24
-2.8%
-5.3%
Net Margin
ARKR
ARKR
PBYI
PBYI
Q4 25
2.2%
Q3 25
-5.1%
16.2%
Q2 25
-7.9%
11.2%
Q1 25
-23.3%
6.5%
Q4 24
7.0%
Q3 24
-10.3%
25.2%
Q2 24
1.3%
-9.6%
Q1 24
-3.4%
-11.0%
EPS (diluted)
ARKR
ARKR
PBYI
PBYI
Q4 25
$0.25
$0.26
Q3 25
$-0.53
$0.17
Q2 25
$-0.96
$0.12
Q1 25
$-2.57
$0.06
Q4 24
$0.88
$0.40
Q3 24
$-1.24
$0.41
Q2 24
$0.18
$-0.09
Q1 24
$-0.40
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARKR
ARKR
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$9.1M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$33.7M
$130.3M
Total Assets
$130.4M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARKR
ARKR
PBYI
PBYI
Q4 25
$9.1M
$97.5M
Q3 25
$11.3M
$94.4M
Q2 25
$12.3M
$96.0M
Q1 25
$11.1M
$93.2M
Q4 24
$13.1M
$101.0M
Q3 24
$10.3M
$96.7M
Q2 24
$11.5M
$96.8M
Q1 24
$10.4M
$107.2M
Total Debt
ARKR
ARKR
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
ARKR
ARKR
PBYI
PBYI
Q4 25
$33.7M
$130.3M
Q3 25
$32.7M
$115.3M
Q2 25
$34.7M
$104.7M
Q1 25
$38.1M
$97.1M
Q4 24
$47.3M
$92.1M
Q3 24
$44.1M
$71.1M
Q2 24
$48.9M
$48.5M
Q1 24
$49.7M
$51.0M
Total Assets
ARKR
ARKR
PBYI
PBYI
Q4 25
$130.4M
$216.3M
Q3 25
$133.5M
$202.9M
Q2 25
$136.3M
$194.9M
Q1 25
$141.9M
$196.2M
Q4 24
$154.6M
$213.3M
Q3 24
$156.0M
$220.7M
Q2 24
$166.5M
$205.0M
Q1 24
$169.6M
$214.1M
Debt / Equity
ARKR
ARKR
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARKR
ARKR
PBYI
PBYI
Operating Cash FlowLast quarter
$-550.0K
$14.4M
Free Cash FlowOCF − Capex
$-1.8M
$14.4M
FCF MarginFCF / Revenue
-4.4%
19.1%
Capex IntensityCapex / Revenue
3.1%
0.0%
Cash ConversionOCF / Net Profit
-0.61×
TTM Free Cash FlowTrailing 4 quarters
$-1.3M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARKR
ARKR
PBYI
PBYI
Q4 25
$-550.0K
$14.4M
Q3 25
$633.0K
$9.7M
Q2 25
$1.9M
$14.1M
Q1 25
$612.0K
$3.6M
Q4 24
$-1.3M
$15.6M
Q3 24
$728.0K
$11.0M
Q2 24
$3.2M
$1.0M
Q1 24
$208.0K
$11.2M
Free Cash Flow
ARKR
ARKR
PBYI
PBYI
Q4 25
$-1.8M
$14.4M
Q3 25
$-989.0K
$9.7M
Q2 25
$1.2M
$14.1M
Q1 25
$290.0K
$3.6M
Q4 24
$-2.0M
$15.6M
Q3 24
$-482.0K
$11.0M
Q2 24
$2.5M
$1.0M
Q1 24
$-148.0K
FCF Margin
ARKR
ARKR
PBYI
PBYI
Q4 25
-4.4%
19.1%
Q3 25
-2.6%
17.7%
Q2 25
2.7%
26.8%
Q1 25
0.7%
7.7%
Q4 24
-4.4%
26.4%
Q3 24
-1.1%
13.7%
Q2 24
5.0%
2.1%
Q1 24
-0.4%
Capex Intensity
ARKR
ARKR
PBYI
PBYI
Q4 25
3.1%
0.0%
Q3 25
4.3%
0.0%
Q2 25
1.5%
0.0%
Q1 25
0.8%
0.1%
Q4 24
1.4%
0.0%
Q3 24
2.8%
0.0%
Q2 24
1.2%
0.0%
Q1 24
0.8%
0.0%
Cash Conversion
ARKR
ARKR
PBYI
PBYI
Q4 25
-0.61×
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
-0.43×
Q3 24
0.54×
Q2 24
4.94×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons